CiteScore measures average citations received per document published in the serial.
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
Overview | |
Publisher | MARY ANN LIEBERT, INC |
Language | English |
Frequency | Bi-monthly |
General Details | |
Language | English |
Frequency | Bi-monthly |
Publication Start Year | 2002 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper1.4k articles received 19.9k citations see all
Assay and Drug Development Technologies has been in operation since 2002 till date.
Assay and Drug Development Technologies published with a Bi-monthly frequency.
In 2023, Assay and Drug Development Technologies published 40 articles.
For Assay and Drug Development Technologies,eISSN is 1557-8127 and pISSN is1540-658X.
Citescore for Assay and Drug Development Technologies is 2.7.
H index for Assay and Drug Development Technologies is 62.
SNIP score for Assay and Drug Development Technologies is 0.56.
SJR for Assay and Drug Development Technologies is Q3.
MARY ANN LIEBERT, INC is the publisher of Assay and Drug Development Technologies.